Neogen Common Stock Net 2010-2025 | NEOG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Neogen common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Neogen common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$228B
Boston Scientific (BSX)	$152.1B
Stryker (SYK)	$144B
EssilorLuxottica (ESLOY)	$137.5B
Medtronic (MDT)	$118B
Lonza Group Ag (LZAGY)	$47.5B
Haleon (HLN)	$43B
ResMed (RMD)	$41.5B
GE HealthCare Technologies (GEHC)	$34B
Agilent Technologies (A)	$33.3B
Terumo (TRUMY)	$27.6B
Koninklijke Philips (PHG)	$26B
Insulet (PODD)	$21.8B
Zimmer Biomet Holdings (ZBH)	$20.2B
Smith & Nephew SNATS (SNN)	$15.9B
Baxter (BAX)	$12.3B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.2B
Bio-Rad Laboratories (BIO)	$7.4B
Lantheus Holdings (LNTH)	$3.7B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.2B
Perrigo (PRGO)	$3.2B
ICU Medical (ICUI)	$2.7B
Haemonetics (HAE)	$2.5B
LeMaitre Vascular (LMAT)	$2.1B
Curaleaf Holdings (CURLF)	$1.8B
AtriCure (ATRC)	$1.8B
Green Thumb Industries (GTBIF)	$1.7B